Delivery Order SPE2DB20D1109-SPE2DB25FN93B
Award Date
4/21/25
Potential Completion Date
4/22/25
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,778.86 Firm Fixed Price contract is for the supply of 4,567,152,479 units of Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of February 5, 2025 and was awarded on February 4, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,831.70, is for the delivery of 4,567,826,839 units of Tamsulosin HCL 0.4 MG capsules. The contract has a fixed-price, firm-fixed-price pricing type and an ultimate completion date of April 8, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,595.50, is for the delivery of 4,567,760,063 capsules of Tamsulosin HCL 0.4 mg. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. This contract is not associated with a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,065.94, is for the supply of 4,567,222,444 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed-price pricing type and a completion date of February 11, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,376.02, is for the delivery of 4,566,770 units of Tamsulosin HCL 0.4 mg Capsules. The contract has an ultimate completion date of December 20, 2024 and is a Firm Fixed Price type contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,092.74, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of January 21, 2025. This contract is a task order under a larger Indefinite Delivery Contract (IDC) held by...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,999.92, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules to support federal healthcare programs. The contract has a firm fixed price pricing type and a period of performance through January 17, 2024. There is no set-aside designation for this award. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tamsulosin HCL 0.4 mg capsules, with a ceiling value of $1,264.83 and a period of performance through April 11, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and is responsible for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,208.34, is for the delivery of 1,000 units of Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of January 29, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,418,131 units of Tamsulosin HCl 0.4 mg capsules. The contract is a firm-fixed price award with a ceiling value of $7,124.76 and an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medications to support military treatment facilities and other federal healthcare programs. This order is...